1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

TABLE 2: Clinical data and results of sclerotherapy in group B
Group B Age (y)/Sex First Aspirates (ml) Infused Ethanol (ml) Ethanol Mixed Aspirates Total Procedure (min) First Follow-up Ultrasonography (mo) Therapeutic Result Complication
1 50/F 6 5 5 30 1 + 
2 46/F 2 2 6 32 24 + Mild pain and intracystic hemorrhage
3 32/F 3.5 3 3.5 27 24 + 
4 31/F 2 2 2 28 2 + 
5 35/F 9 9 9 30 24 + 
6 60/F 2 2 3 33 1 + Mild pain and intracystic hemorrhage
7 32/F 2 1.5 2 26 2 + 
8 24/F 8 5 7 30 1 − Mild pain
9 66/F 2 2 2 31 1 + Mild pain
10 74/F 2 2 2 28 8 + 
11 41/F 4 4 6 29 2 + Intracystic hemorrhage
12 45/M 5 5 5 27 3 + 
13 31/F 8 6 8 32 1 + Mild pain
14 42/F 5 5 6 30 3 + Intracystic hemorrhage
15 32/F 4 4 4 28 6 + 
16 60/F 8 9 7 30 3 + 
17 43/F 2 2 1.2 29 4 + 
18 66/F 20 12 7 33 1 + 
19 37/F 25 20 20 31 2 + Drunken sense
20 55/M 4 4 4 27 2 + 
21 46/F 4 4 2 33 1 + Mild dizziness
22 20/F 1 1.5 1 32 5 + Mild pain and facial flushing
23 49/F 4 4 3.5 28 1 + 
24 29/F 1 1 1.2 30 1 + Mild pain
25 41/M 5 5 2 36 1 + Moderate pain and perithyroidal leakage
26 47/F 17 10 12 34 1 − Intracystic hemorrhage
27 66/F 4 4 4.5 31 3 + Intracystic hemorrhage
28 43/F 1 1 1 30 1 + 
29 41/F 8 8 6.5 34 2 + Mild pain
30 75/M 50 20 22 38 1 + Mild pain and intracystic hemorrhage
Mean 45.3 7.3 5.4 5.5 30.6 4.4 
Note.—+ indicates complete disappearance of the cystic portion of the thyroid nodule; −, incomplete disappearance of the cystic portion of the thyroid nodule.